Clobenpropit Dihydrobromide
CAS: 145231-35-2
Ref. 3D-VFA23135
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Información del producto
- Carbamimidothioic acid, N-[(4-chlorophenyl)methyl]-, 3-(1H-imidazol-5-yl)propyl ester, hydrobromide (1:2)
- Clobenpropit dihydrobromide
- Carbamimidothioic acid, [(4-chlorophenyl)methyl]-, 3-(1H-imidazol-4-yl)propyl ester, dihydrobromide
Clobenpropit dihydrobromide is an acetylcholine receptor antagonist that is used in the treatment of prostate cancer. It has been shown to inhibit proliferation and induce apoptosis in prostate cancer cells, as well as inhibit the growth of du-145 cells. Clobenpropit dihydrobromide also induces antibody production by T-cells and enhances the immune response. Clobenpropit dihydrobromide binds to histamine receptors, causing a non-selective cation influx into cells. This leads to the opening of voltage-gated calcium channels on the cell membrane, which triggers an immune reaction against cancerous cells.
Propiedades químicas
Consulta técnica sobre: 3D-VFA23135 Clobenpropit Dihydrobromide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
